Anavex Life Sciences Corp (AVXL)

[Gator328]

Depends what the terms are. If SAVA thinks that AVXL is going to beat it to market with a superior product, but that the two drugs may complement each other, the SAVA CEO may end up deciding that part of something is better than all of nothing.

Think about it: why would anyone continue the SAVA trial and -maybe- get decent long-term results when A273 is available with years of clinical data available?

There was a company whose name escapes me, I will try to remember it and will post if I do, but they were developing a promising drug but another company ended up beating them to market and they basically shut everything down and pivoted to elsewhere in the pipeline. The drug may have worked but it wasn't going to be the standard of care so why spend time and money pursuing it? I think this may be a situation SAVA finds itself in if A273 is as good as we hope it is.

I wasn't proposing a 50/50 partnership. I just think that two small companies teaming up provides more profit potential for both sides than essentially being acquired by a larger company. Manufacturing and marketing can both be outsourced initially.

The deal would also benefit AVXL because SAVA has an interesting blood test, SavaDX, in development that looks promising.